Close Menu

Goodbye, Dolly?

SciAm has an article and excerpts of an interview with Ian Wilmut, the first person to use somatic cell nuclear transfer to clone a mammal. Wilmut has almost entirely switched his research focus to creating iPS cells because, like many others, he sees that weeding through the ethical and technical issues around SCNT just isn't worth it.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.